Rejected at 12:45 a.m. Nov, 01, 2023 ] by dollajas
Author: Patreek
Related Note: 1472502616617 1
Rationale for change

Not all Ca2+ channel blockers vasoconstrict, only dihydropyridine Ca2+ channel blockers do.
This is consistent with the FA image in the card "Dihydropyridine...angina (including Prinzmetal)"

Rejection reason

comment. not correct

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::07_Calcium_Channel_Blockers_(MOA,_Indications,_AR,_CI) #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::08_Antianginal_Drugs #AK_Step2_v12::#B&B::02_Cardio::02_Ischemic_Heart_Disease::01_Coronary_Artery_Disease::Extra #AK_Step1_v12::#AMBOSS::CA0qNi #AK_Step1_v12::#Bootcamp::Cardiology::23_Stable_Angina_and_Atherosclerosis::06_Vasospastic_Angina #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #PANCE::CARDIO::coronary_artery_disease #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::02_Calcium_Channel_Blockers #AK_Other::AnKing_Image::Mujeeb::Anginas_vs_ACS #AK_Step2_v12::#FirstAid::01_Cardiovascular::07_Coronary_Artery_Disease::03_Prinzmetal_(Variant)_Angina #AK_Step2_v12::#Bootcamp::Medicine::01_Cardiology::01_Coronary_Artery_Disease::10_Additional_Considerations_for_Coronary_Ischemia #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#UWorld::Step::2723 #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::01_Hypertension_Treatment #AK_Other::AnKing_Image::!Subjects::Cardiology::Anginas_vs_ACS #AK_Step1_v12::#SketchyPharm::02_Cardio_&_Renal::03_Antihypertensives::01_Calcium_channel_blockers #AK_Step2_v12::#AMBOSS::pF0LQ3 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #PANCE::EOR::Family_med #AK_Step1_v12::#NinjaNerd::12_Neurology::03_Pathology::07_Subarachnoid_Hemorrhage_(Etiology,_Pathophysiology,_Clinical_Features,_Treatment,_Complications) #AK_Step2_v12::#UWorld::COMLEX::28535 #AK_Step1_v12::#FirstAid::07_Cardiovascular::05_Pharm::03_Calcium_channel_blockers #AK_Step1_v12::#FirstAid::07_Cardiovascular::05_Pharm::06_Antianginal_Therapy #AK_Step2_v12::#COMBANK::51918 #AK_Step1_v12::#Pixorize::03_Pharmacology::22_Cardiovascular_(New)::03_DHP_Calcium_Channel_Blockers #PANCE::EOR::Surgery #PANCE::EOR::IM #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::^Systems::Cardio::Pharmacology #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::09_Antihypertensive_Drugs #AK_Step1_v12::#OME::PreClinical::Cardiac #AK_Step1_v12::#B&B::06_Cardio::02_Cardiac_Ischemia::06_Stable_Angina::Extra